Alpha Teknova reports Q2 2024 rev $9.4-9.6M, reaffirms FY guidance $35-38M

Alpha Teknova, Inc.

2024-Q2 EPS reported -$0.33 revenue$18,904,000

Q2 2024 total revenue $9.4-9.6M, down 17-18% YoY but up 7-9% adjusting for large prior-year order.
FY 2024 revenue guidance reaffirmed at $35-38M; free cash outflow <$18M.
Headcount reduced >40% from Q2 2022 peak to 169; cash used in Q2 was $3.0-3.4M.
Clinical Solutions customers grew from 34 to 43; Lab Essentials customers from 2,829 to 2,913.
No single direct customer >$1M YTD; full Q2 results expected August 13, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.